The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The cluster randomised crossover (CRXO) design is gaining popularity in trial settings where individual randomisation or parallel group cluster randomisation is not feasible or practical. Our aim is to stimulate discussion on the content of a reporting guideline for CRXO trials and to assess the reporting quality of published CRXO trials. METHODS: We undertook a systematic review of CRXO trials. Searches of MEDLINE, EMBASE, and CINAHL Plus as well as citation searches of CRXO methodological articles were conducted to December 2014. Reporting quality was assessed against both modified items from 2010 CONSORT and 2012 cluster trials extension and other proposed quality measures. RESULTS: Of the 3425 records identified through database searching, 83 trials met the inclusion criteria. Trials were infrequently identified as "cluster randomis(z)ed crossover" in title (n = 7, 8%) or abstract (n = 21, 25%), and a rationale for the design was infrequently provided (n = 20, 24%). Design parameters such as the number of clusters and number of periods were well reported. Discussion of carryover took place in only 17 trials (20%). Sample size methods were only reported in 58% (n = 48) of trials. A range of approaches were used to report baseline characteristics. The analysis method was not adequately reported in 23% (n = 19) of trials. The observed within-cluster within-period intracluster correlation and within-cluster between-period intracluster correlation for the primary outcome data were not reported in any trial. The potential for selection, performance, and detection bias could be evaluated in 30%, 81%, and 70% of trials, respectively. CONCLUSIONS: There is a clear need to improve the quality of reporting in CRXO trials. Given the unique features of a CRXO trial, it is important to develop a CONSORT extension. Consensus amongst trialists on the content of such a guideline is essential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“while 19 of 83 clustered cross-over studies were unclear as to whether both clustering and cross-over effects were included in the analysis (65).”
From Issues with data and analyses: Errors, underlying themes, and potential solutions (2018) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,171
Consort 2010 statement: extension to cluster randomised trials
Campbell, M. K., Piaggio, G., Elbourne, D. R., Altman, D. G., & for the CONSORT Group (2012) · BMJ · doi:10.1136/bmj.e5661 · Cited by 3,510 · cited 10×
“To facilitate discussion on presenting the flow of the number of clusters, cluster-period, and participants through a CRXO, we outline possible modifications to the flow diagram in the CONSORT 2012 cluster trials extension [12] and present a possible flow diagram in Fig.”
BackgroundMethodInfluentialMoher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755 · cited 1×
“The CONSORT statement was first published in 1996, and has since been twice revised, first in 2001 [10] and then in 2010 [11].”
MethodMoher, D. (2001) · JAMA · doi:10.1001/jama.285.15.1987 · Cited by 2,545
Guidance for Developers of Health Research Reporting Guidelines
Moher, D., Schulz, K. F., Simera, I., & Altman, D. G. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000217 · Cited by 1,437 · cited 4×
“Recommended next steps would include setting up a consensus process, including participants with relevant expertise, to decide upon the specific items and their wording [9].”
BackgroundInfluentialThe stepped wedge cluster randomised trial: rationale, design, analysis, and reporting
Hemming, K., Haines, T. P., Chilton, P. J., Girling, A. J., & Lilford, R. J. (2015) · BMJ · doi:10.1136/bmj.h391 · Cited by 1,410 · cited 2×
“Several of these items have been adapted from recommendations for reporting steppedwedge trials [13]:”
MethodCONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.
Schulz, K. F., Altman, D. G., & Moher, D. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.02.005 · Cited by 1,022
Hopewell, S., Clarke, M., Moher, D., Wager, E., Middleton, P., Altman, D. G., Schulz, K. F., & and the CONSORT Group (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050020 · Cited by 674 · cited 3×
“The primary reasons for including a description of the trial design in the title and abstract are to ensure appropriate indexing in electronic databases [12, 14] and to alert the readers to the design so that they are less likely Arnup et al.”
BackgroundHopewell, S., Dutton, S., Yu, L.-M., Chan, A.-W., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c723 · Cited by 504 · cited 2×
“The completeness of reporting risk of bias domains for CRXO trials was better than previously observed estimates for the domains: method of random sequence generation, method of allocation concealment, and blinding [8, 18, 19, 21].”
BackgroundMethod
Cited by
Review of recent methodological developments in group-randomized trials: part 2—analysis
Turner, E. L., Prague, M., Gallis, J. A., Li, F., & Murray, D. M. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303707 · Cited by 195
Review of Recent Methodological Developments in Group-Randomized Trials: Part 1—Design
Turner, E. L., Li, F., Gallis, J. A., Prague, M., & Murray, D. M. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303706 · Cited by 165
Issues with data and analyses: Errors, underlying themes, and potential solutions
Brown, A. W., Kaiser, K. A., & Allison, D. B. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708279115 · Cited by 157
Hemming, K., Taljaard, M., Weijer, C., & Forbes, A. B. (2020) · BMJ · doi:10.1136/bmj.m3800 · Cited by 53
Self-citationLegrand, M. M., Kothari, R. P., Fong, N., Palaniappa, N. C., Boldt, D., Chen, L., Kurien, P. A., Gabel, E., Sturgess-DaPrato, J., Harhay, M. O., et al. (2023) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.02.004 · Cited by 43
Metadata
- Authors
- Arnup, S. J., Forbes, A. B., Kahan, B. C., Morgan, K. E., & McKenzie, J. E.
- Affiliations
- The Alfred Hospital (AU)
- Queen Mary University of London (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- McKenzie, Joanne E.
- Venue
- Trials
- Published
- 2016-12
- Volume
- 17
- Issue
- 1
- Pages
- 575-575
- ISSN
- 1745-6215 (ISSN-L)
- PMC
- PMC5142135
- OpenAlex
- W2560774895
- Cited by
- 20
- References
- 23
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 4 · 2021: 1 · 2020: 5 · 2018: 2 · 2017: 3
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Trials (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
- Funders
- Monash University Graduate Scholarship (20158293)
- National Health and Medical Research Council (1035261)
- National Institute for Health Research (MET-12-16)
- National Health and Medical Research Council (AU) (1072366)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Health Sciences › Health Professions › General Health Professions › Health Policy Implementation Science
- Keywords
- reporting quality, reporting guidelines, CONSORT extension, residual effects, intra-cluster correlation, bias assessment
- MeSH terms
- Humans, Research Design, Bias, Randomized Controlled Trials as Topic, Cross-Over Studies, Research Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality. https://app.cochat.ai/papers/10.1186/s13063-016-1685-6
- The paper
- Arnup, S. J., Forbes, A. B., Kahan, B. C., Morgan, K. E., & McKenzie, J. E. (2016). The quality of reporting in cluster randomised crossover trials: proposal for reporting items and an assessment of reporting quality. Trials. https://doi.org/10.1186/s13063-016-1685-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

